Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0160531002
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02479648 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | SCHEDULE D | 1 | EMICIZUMAB | 60 MG / 0.4 ML |
| Marketed | 02479648 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | PRESCRIPTION | 1 | EMICIZUMAB | 60 MG / 0.4 ML |
| Marketed | 02479656 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | SCHEDULE D | 1 | EMICIZUMAB | 105 MG / 0.7 ML |
| Marketed | 02479656 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | PRESCRIPTION | 1 | EMICIZUMAB | 105 MG / 0.7 ML |
| Marketed | 02479664 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | SCHEDULE D | 1 | EMICIZUMAB | 150 MG / ML |
| Marketed | 02479664 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | PRESCRIPTION | 1 | EMICIZUMAB | 150 MG / ML |
| Approved | 02556057 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | PRESCRIPTION | 1 | EMICIZUMAB | 300 MG / 2 ML |
| Approved | 02556057 | HOFFMANN-LA ROCHE LIMITED | HEMLIBRA | Human | Yes | SCHEDULE D | 1 | EMICIZUMAB | 300 MG / 2 ML |
Application information
Related information
Contact us
Version 4.0.3